-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
CS-M1996
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/876708-01-9.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 876708-01-9 |
| Description | CS-M1996 is a 4'-Azidocytidine analogue. It can inhibit Hepatitis C virus replication. |
Product Information
| Synonyms | CS-M1996; CS M1996; CSM1996; 2,4(1H,3H)-PyriMidinedione, 1-(4-C-azido-β-D-arabinofuranosyl)- (9CI);Nucleoside-Analog-2;1-[(2R,3S,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
| Molecular Weight | 285.21 |
| Molecular Formula | C9H11N5O6 |
| Canonical SMILES | C1=CN(C(=O)NC1=O)C2C(C(C(O2)(CO)N=[N+]=[N-])O)O |
| InChI | InChI=1S/C9H11N5O6/c10-13-12-9(3-15)6(18)5(17)7(20-9)14-2-1-4(16)11-8(14)19/h1-2,5-7,15,17-18H,3H2,(H,11,16,19)/t5-,6-,7+,9+/m0/s1 |
| InChIKey | FHPJZSIIXUQGQE-XZMZPDFPSA-N |
| Purity | >98 % |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Application | CS-M1996 can inhibit Hepatitis C virus replication. |
| Shelf Life | 2 month in rt, long time |
| Storage | -20°C Freezer |
| Complexity | 517 |
| Exact Mass | 285.07093309 |
| In Vitro | Nucleoside-Analog-2 is a 4'-Azidocytidine analogue against Hepatitis C virus (HCV) replication. Reference to compound 12. |
| Target | Nucleoside Antimetabolite/Analog; HCV |
| XLogP3-AA | -1.5 |
